Boris Guiu

Title: The Innovative Contributions of Boris Guiu

Introduction

Boris Guiu is a notable inventor based in Daix, France. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative approach has led to the development of a unique formulation that combines Lipiodol with anti-tumor agents.

Latest Patents

Boris Guiu holds a patent for a pharmaceutical composition that includes Lipiodol and a molecule with anti-tumor activity, along with hydroxyethyl starch. This invention, titled "Lipiodol-based anti-tumour emulsion for treating cancer," outlines a composition that can effectively treat cancer. The formulation specifies that it contains between 0.004% and 0.2% by weight of idarubicin, between 0.38% and 2.25% by weight of hydroxyethyl starch, and between 60% and 68% by weight of Lipiodol, with water for injection or physiological saline as needed.

Career Highlights

Throughout his career, Boris Guiu has worked with reputable companies such as Guerbet and Chu De Dijon. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Boris Guiu has collaborated with notable professionals in his field, including Mathieu Boulin and Jean-Pierre Cercueil. These partnerships have likely enhanced his research and development efforts.

Conclusion

Boris Guiu's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future developments in pharmaceutical compositions.